New Entrants into Clinical Trials for Targeted Therapy of Breast Cancer: An Insight

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Breast cancer complexity arises from diverse molecular alterations.
• Recent advancements include targeted therapies and signal transduction pathway inhibitors.
• Conventional treatments (chemotherapy, hormone therapy, radiotherapy) are often combined with novel drugs.

Purpose of the Study:

• To review recently studied target molecules and their inhibitors for breast cancer treatment.
• To highlight emerging therapies with potential for localized and advanced breast carcinoma.
• To discuss challenges associated with novel breast cancer therapies.

Main Methods:

• Literature review of recently studied target molecules and inhibitors in breast cancer.
• Analysis of clinical development status for novel targeted therapies.
• Evaluation of treatment challenges including dosage, patient selection, and side effect management.

Main Results:

• Identification of several target molecules with indications in breast carcinoma.
• Overview of inhibitors in clinical development for breast cancer.
• Discussion of challenges in implementing novel therapies, such as dosage and patient selection.

Conclusions:

• Emerging targeted therapies and inhibitors show significant potential for improving breast cancer care.
• Careful consideration of challenges like dosage, patient selection, and side effect management is crucial.
• Continued research and clinical development of novel agents are vital for future breast cancer treatment strategies.